Zum Inhalt

HealthOSArzneimittel

Arbeitsbereiche

Nachschlagen

Wirkstoffe & Arzneimittelsicherheit

Exakte Wirkstoffkennungen und zitierbare Passagen zu Wechselwirkungen, Gegenanzeigen und Nebenwirkungen.

Ein Paarvergleich findet Originalpassagen, die den anderen Wirkstoff wörtlich nennen. Aussagen gelten für das jeweilige Präparat und seine Formulierung. Klassenbegriffe und abweichende Synonyme können fehlen. Kein Treffer bedeutet nicht, dass keine Wechselwirkung besteht.

RxNorm 05-Oct-2026 · geprüft 2026-10-25 · 1009 Präparate · 54812 Quellenpassagen · 148 strukturierte Aussagen. Automatisch aktualisiert, ohne menschliche Freigabe.

Quellenpassagen (1)

Nebenwirkungen · Besremi

Besremi 250 micrograms/0.5 mL solution for injection in pre-filled pen Besremi 500 micrograms/0.5 mL solution for injection in pre-filled pen · Abschnitt 4.8 · PDF-Seite 8–9

HOS-135535 · Präparat HOS-097722

8 Nervous system common headache, dizziness, hypoesthesia, somnolence, disorders paraesthesia uncommon polyneuropathy, peripheral motor neuropathy, radiculopathy, migraine, mental impairment, tremor, aura Eye disorders common dry eye uncommon retinal haemorrhage#, retinal exudates#, visual impairment, visual acuity reduced, vision blurred, ocular discomfort, eczema eyelids rare retinopathy#, optic neuropathy#, retinal artery occlusion#, retinal vein occlusion#, very rare blindness# not known retinal detachment# Ear and labyrinth uncommon deafness, tinnitus, vertigo disorders Cardiac disorders common atrial fibrillation uncommon myocardial infarction#, atrioventricular block, intracardiac thrombus, aortic valve incompetence, cardiovascular disorder rare cardiomyopathy#, angina pectoris# very rare myocardial ischemia# Vascular disorders common microangiopathy uncommon Raynaud's phenomenon, hypertension, haematoma, flushing Respiratory, thoracic common dyspnoea and mediastinal uncommon pneumonitis, cough, epistaxis, throat irritation disorders very rare lung infiltration# not known pulmonary fibrosis#, pneumonia#, pulmonary arterial hypertension#* Gastrointestinal common diarrhoea, nausea, abdominal pain, constipation, disorders abdominal distension, dry mouth uncommon gastritis, abdominal wall disorder, flatulence, frequent bowel movements, odynophagia, gingival bleeding not known tooth disorder#, periodontal disease# Hepatobiliary very common gamma-glutamyltransferase increased disorders common liver disorder, alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased uncommon hepatotoxicity, hepatitis toxic, hepatomegaly, porphyria non-acute rare hepatic failure# Skin and common pruritus, alopecia, rash, erythema, psoriasis, xeroderma, subcutaneous tissue dermatitis acneiform, hyperkeratosis, hyperhidrosis, dry disorders skin uncommon photosensitivity reaction, skin exfoliation, nail dystrophy not known skin depigmentation# Musculoskeletal and very common arthralgia, myalgia connective tissue common Sjogren's syndrome, arthritis, pain in extremity, disorders musculoskeletal pain, bone pain, muscle spasms uncommon muscular weakness, neck pain, groin pain Renal and urinary uncommon cystitis haemorrhagic, dysuria, micturition urgency, disorders urinary retention

Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.

Vollständigen Kontext in der EMA-Fachinformation lesen →
Quellennachweis

Version 2026-04-24T15:08:00Z · SHA-256 b821a9d463d0e9f05f3c2788ab2015a721e1b4a1ebc9433fe4d8072c0d2af2de · Passage 8f60e5cc5fd5a998f2ecf0cebfd588857abee35cdfa901d3075400c7dbef4831 · Zeichen 2948–6631 im Abschnitt

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.